New Delhi: The first nasal vaccine for COVID-19 developed by Bharat Biotech has received regulatory approval for Phase II and III clinical trials. The...
Key HighlightsStaggered Mutations: The BA.3.2 variant carries 70 to 75 mutations in its spike protein, significantly more than previous dominant strains.Global Presence: Originating in...
New Delhi: Will taking a loan to become expensive once again? This apprehension is being expressed before the meeting of the Monetary Policy Committee...